The challenges of lung cancer in China

Journal of Cancer Research and Therapeutics

Volumn 9, Issue SUPPL. 2, 2013, Pages

  Liu, Qian ^a   Zhou, Qinghua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GEFITINIB; PROTEIN KINASE C; PROTEIN TYROSINE KINASE INHIBITOR; STAT3 PROTEIN; STATHMIN;

CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURGERY; CELL POLARITY; CHINA; DISEASE ASSOCIATION; EDITORIAL; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; INTERMETHOD COMPARISON; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MOLECULAR DYNAMICS; PROTEIN EXPRESSION; SMOKING; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA; TOBACCO; TUMOR GENE;

CARCINOMA, NON-SMALL-CELL LUNG; CHINA; HUMANS; LUNG NEOPLASMS;

EID: 84885585574     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.119098     Document Type: Editorial

References (18)

1. Herbst RS, Heymach JV, Lippman SM. Lung Cancer. N Engl J Med 2008;359:1367-80.
2. Chen W, Zheng R, Zhang S, Zou X, Zhao P, He J. Lung cancer incidence and mortality in China, 2009. Thorac Cancer 2013;4:102-8.
3. Chen WQ, Zheng RS, Zeng HM. Bayesian age-period-cohort prediction of lung cancer incidence in China. Thorac Cancer 2011;2:149-55.
4. She J, Yang P, Hong Q, Bai C. Lung cancer in China: Challenges and interventions. Chest 2013;143:1117-26.
5. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011;144:646-74.
6. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003;3:733-44.
7. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002;2:372-7.
8. Fang X, Wang X, Bai C. COPD in China: The burden and importance of proper management. Chest 2011;139:920-9.
9. Han JX, Ma L, Zhang HW, Liu X, Zheng SH, Gan DK, et al. A cross sectional study of passive smoking of non-smoking women and analysis of influence factors on women passive smoking. Wei Sheng Yan Jiu 2006;35:609-11.
10. Zhang J, Ou JX, Bai CX. Tobacco smoking in China:prevalence, disease burden, challenges and future strategies. Respirology 2011;16:1165-72.
11. Couraud S, Zalcman G, Milleron B, Morin F, Souquet PJ. Lung cancer in never smokers-a review. Eur J Cancer 2012;48:1299-311.
12. Feldser DM, Kostova KK, Winslow MM, Taylor SE, Cashman C, Whittaker CA, et al. Stage-specific sensitivity to p53 restoration during lung cancer progression. Nature 2010;468:572-5.
13. Sequist LV, Bell DW, Lynch TJ, Haber DA. Molecular predictors of response to epidermal growth factor receptor antagonists in nonsmall-cell lung cancer. J Clin Oncol 2007;25:587-95.
14. Liu Y, He W, Long J, Pang F, Xian L, Chen M, et al. Natural selection and functional diversification of the epidermal growth factor receptor EGFR family in vertebrates. Genomics 2013;101:318-25.
15. Uribe P, Gonzalez S. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: Molecular bases for EGFRtargeted therapy. Pathol Res Pract 2011;207:337-42.
16. Antonicelli A, Cafarotti S, Indini A, Galli A, Russo A, Cesario A, et al. EGFR-targeted therapy for non-small cell lung cancer: Focus on EGFR oncogenic mutation. Int J Med Sci 2013;10:320-30.
17. Li B, Wang C, Zhang Y, Zhao XY, Huang B, Wu PF, et al. Elevated PLGF contributes to small-cell lung cancer brain metastasis. Oncogene 2013;32:2952-62.
18. Salgia R, Hensing T, Campbell N, Salama AK, Maitland M, Hoffman P, et al. Personalized treatment of lung cancer. Semin Oncol 2011;38: 274-83.